CJC-1295 DAC Legal Status: Research Guide & Regulatory Analysis

At a glance: Legal status of CJC-1295 DAC for research

In the United States and most international jurisdictions, CJC-1295 DAC is not classified as a scheduled controlled substance. It remains fully legal to acquire, hold, and evaluate in laboratory settings for non-clinical research, analytical testing, and standard in vitro experiments. Because it is not approved by the U.S. Food and Drug Administration (FDA) for human clinical use, sale is strictly restricted to Qualified Research Institutions, laboratories, and individual scientific investigators under Laboratory Research Use Only (RUO) designations.

Researchers looking to order 5 mg vials of CJC-1295 DAC must ensure their protocols remain entirely within non-clinical parameters. Legitimate vendors verify identity and purity using reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS) to guarantee that experimental results are accurate and reproducible. Compliance requires purchasing strictly from suppliers that maintain transparent analytical data and strictly enforce RUO conditions.

Is CJC-1295 DAC legal to purchase for research in the United States?

When evaluating whether CJC-1295 DAC legal status allows domestic procurement, the federal classification under the Controlled Substances Act (CSA) is the foundational benchmark. CJC-1295 with DAC (Drug Affinity Complex) is not listed on any schedule of the CSA. Consequently, federal law does not prohibit the chemical synthesis, sale, or laboratory handling of this peptide compound when intended exclusively for in vitro assaying, cellular signaling studies, or animal model experiments.

However, commercial vendors and research buyers must navigate federal regulations regarding intent and labelling. Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), selling unapproved peptides for human consumption, therapeutic dosing, or body enhancement is illegal. For this reason, reputable suppliers enforce strict commercial terms, providing products explicitly labelled for research purposes only. When searching for cjc 1295 dac legal suppliers, investigators should rely on established entities like PX1 Research that maintain clear compliance boundaries, verifiable purity records, and full batch traceability.

Understanding CJC-1295 DAC classification and chemical profile

CJC-1295 DAC is a synthetic analog of growth hormone-releasing hormone (GHRH), specifically engineered to extend the biological half-life of natural GHRH peptides. The native GHRH molecule consists of 44 amino acids, though its biological activity resides in the N-terminal 29-amino-acid sequence (GRF 1-29). Standard GRF 1-29 undergoes rapid enzymatic degradation in plasma by dipeptidyl peptidase IV (DPP-IV), resulting in a biological half-life of under 10 minutes.

To overcome this rapid clearance, researchers added a Drug Affinity Complex (DAC) to the modified GRF 1-29 chain. The DAC modification consists of a lysine linker bound to a maleimidohexanoic acid reactive group. Upon administration in animal models, this maleimide group forms a stable covalent bond with circulating endogenous albumin at the Cys34 residue. Preclinical studies suggest that this albumin-binding mechanism shields the peptide from enzymatic cleavage and renal clearance, extending its half-life to several days and sustaining growth hormone (GH) and downstream insulin-like growth factor 1 (IGF-1) levels for tissue repair research.

CJC-1295 DAC vs CJC-1295 No DAC: Regulatory and structural distinctions

A common point of confusion among research staff is the distinction between CJC-1295 with DAC and CJC-1295 without DAC (frequently designated as Modified GRF 1-29). From a legal and regulatory standpoint, both variants share identical non-controlled, RUO classifications in the United States. Neither peptide is a controlled substance, and both may be legally purchased for legitimate scientific investigation.

Structurally and pharmacodynamically, however, the two molecules behave differently in research models:

• **CJC-1295 DAC:** Contains the maleimidohexanoic acid group, permitting irreversible binding to serum albumin. This results in a prolonged half-life (approximately 6–8 days in animal models) and produces a continuous, elevated baseline release of GH and IGF-1.

• **CJC-1295 No DAC:** Lacks the albumin-reactive group. Investigators often buy CJC-1295 No DAC vials when experimental protocols require short-lived, pulsatile GHRH stimulation (half-life approximately 30 minutes) that mimics natural physiological GH release patterns.

Researchers exploring the broader category of secretagogues can review detailed chemical structures in our comprehensive GHRH research catalog to determine which half-life profile aligns with their experimental design.

Is CJC-1295 DAC legal in Deutschland and Europe?

Queries regarding cjc-1295 dac legal in deutschland require examining European Union regulations and specific national drug legislation in Germany. In Germany, the regulatory landscape is governed primarily by the German Medicines Act (Arzneimittelgesetz or AMG) and the New Psychoactive Substances Act (Neue-psychoaktive-Stoffe-Gesetz or NpSG). CJC-1295 DAC is not classified under the Narcotics Act (Betäubungsmittelgesetz or BtMG), nor does it fall under the NpSG, as it is a peptide analog rather than a psychoactive substance.

Under the AMG, importing or selling unapproved medicinal products for human therapeutic use is illegal in Germany. However, importing synthetic research chemicals strictly for non-clinical laboratory analysis by licensed institutions or scientific researchers remains permissible, provided custom declarations accurately document the non-medicinal, research-only intent. International researchers must verify local customs regulations before placing orders, as administrative controls on peptide imports can vary between EU member states.

How to vet a research peptide supplier for CJC-1295 DAC (Red flags to avoid)

The integrity of experimental data depends entirely on the chemical purity and stability of the research compounds used. Unfortunately, the research peptide market contains numerous vendors distributing sub-standard or mislabelled material. When evaluating suppliers for research peptides, laboratories should watch for these explicit red flags:

• **Lack of lot-specific COAs:** A generic batch report or static image that does not change between orders indicates a vendor that does not conduct independent analytical testing for every production run.

• **Presence of human dosing or administration guides:** Sites offering medical advice, injection instructions, or human dosage calculators violate federal compliance standards and indicate non-compliant supply chains.

• **Absence of endotoxin testing:** Peptides intended for cell culture or animal assays must undergo bacterial endotoxin testing (LAL assay). High endotoxin levels trigger unwanted inflammatory responses that ruin study validity.

• **Opaque sourcing and missing batch tracking:** Legitimate suppliers clearly identify batch numbers, source facilities, and offer transparent analytical records accessible via public batch databases or QR codes.

• **Unrealistically low pricing:** Ultra-low prices often signal offshore mass-synthesis facilities operating without cleanroom controls, resulting in truncated peptide sequences, heavy metal contamination, or TFA residual toxicity.

Vendor evaluation criteria: Quality standards for research peptides

To help laboratory procurement officers compare vendors objectively, PX1 Research adheres to documented quality control standards that exceed standard commercial practices. The following matrix illustrates essential vendor selection criteria:

• **Purity Verification:** Standard vendors rely on self-reported factory metrics (95%+ target). PX1 Research guarantees ≥99.0% purity verified by independent HPLC testing on every lot.

• **Mass Spectrometry:** Standard vendors rarely provide tandem mass spec (MS) identity profiles. PX1 Research includes full MS spectra proving precise molecular weight and sequence identity.

• **Endotoxin Assessment:** Standard vendors omit bacterial endotoxin data entirely. PX1 Research quantifies endotoxin content (<0.1 EU/mg) to ensure compatibility with sensitive cellular assays.

• **Domestic Manufacturing & Logistics:** Standard vendors drop-ship unverified batches from overseas hubs. PX1 Research manufactures and packages peptides in US-based facilities with same-day dispatch from California and Arizona hubs.

• **Lot Traceability & Storage:** Standard vendors store peptides at room temperature in unmonitored facilities. PX1 Research maintains cold-chain storage and provides instant lot-specific COA verification.

To review full analytical methodology or request batch reports, investigators can explore our public peptide research library or contact our technical support team.

Laboratory handling, reconstitution, and storage protocols

Maintaining peptide stability during laboratory handling is essential to prevent hydrolysis, oxidation, or aggregation. CJC-1295 DAC is supplied as a lyophilized (freeze-dried) powder sealed under vacuum or inert gas atmosphere. Upon receipt, lyophilized vials should be stored at -20°C for long-term stability, or 2°C to 8°C for short-term project windows.

Reconstitution should be performed under a laminar flow hood using sterile laboratory grade solvent, such as bacteriostatic water (0.9% benzyl alcohol) or sterile normal saline, depending on assay requirements. Reconstitute by directing the solvent stream gently against the glass vial wall rather than directly onto the lyophilized cake. Avoid violent shaking or vortexing, which can denature the peptide structure; instead, gently swirl the vial until the powder dissolves completely. Once dissolved, liquid aliquots should be refrigerated at 2°C to 8°C and evaluated within 30 days, or frozen in single-use experimental aliquots at -80°C to prevent freeze-thaw degradation cycles.

Synergistic research compounds: Pairing GHRH analogs with GHRPs

In cell culture models and preclinical neuroendocrine research, investigators frequently study the combined effects of GHRH analogs alongside Growth Hormone Releasing Peptides (GHRPs). While GHRH analogs act on the growth hormone-releasing hormone receptor (GHRH-R), GHRPs act as agonists at the ghrelin/growth hormone secretagogue receptor (GHS-R1a).

Preclinical data indicate that dual stimulation of both receptor pathways produces a synergistic stimulation of GH release that significantly exceeds the mathematical sum of either peptide administered alone. Common GHRP compounds evaluated alongside CJC-1295 DAC in dual-receptor research protocols include:

• Ipamorelin — A selective ghrelin receptor agonist known for minimal impact on plasma cortisol and prolactin levels during secretagogue assays.

• GHRP-6 — A hexapeptide ghrelin agonist widely studied for its ghrelin-mimetic metabolic signaling in tissue culture studies.

Researchers interested in evaluating multiple secretagogue classes within single experimental matrices can review our complete inventory of catalog compounds through our all peptides directory.

Ordering CJC-1295 DAC from PX1 Research

PX1 Research provides researchers and academic institutions with simple, transparent procurement for high-purity peptides. When you order CJC-1295 DAC 5 mg vials or larger bulk quantities, your order is processed directly through our US supply chain.

Every shipment includes:

• Lyophilized peptide vials in protective, tamper-evident packaging.

• Direct access to downloadable, lot-specific COA reports showing RP-HPLC and MS verification.

• Same-day shipping for all orders placed before 3:00 PM EST, Monday through Friday, dispatched from our dual distribution centers in California and Arizona.

• Full tracking visibility and responsive, US-based technical support for all product inquiries.

Institutions requiring high-volume supplies or custom synthesis solutions for large-scale studies can submit inquiries through our dedicated wholesale peptide program. To browse our current stock and instantly download analytical certificates, visit our main catalog today.